When combined with CHOEP, chidamide conferred a 60.2% ORR, with a complete response rate of 40.7%; however, the addition of etoposide did not offer a benefit in terms of event-free survival for the PCTL except for the ALK + ALCL [108]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.